欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5107/001
药品名称Fesoterodine Accord 8 mg tabletten met verlengde afgifte
活性成分
    • fesoterodine hydrogen fumarate 8.0 mg
剂型Prolonged-release tablet
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht Netherlands
参考成员国 - 产品名称Netherlands (NL)
Fesoterodine Accord 8 mg tabletten met verlengde afgifte
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Ireland (IE)
    • Sweden (SE)
    • Norway (NO)
      Fesoterodin Accord
    • Finland (FI)
    • Hungary (HU)
    • Cyprus (CY)
      Oxiblim prolonged release tablets
    • Czechia (CZ)
      Fesoterodine Accord
    • United Kingdom (Northern Ireland) (XI)
许可日期2021/05/07
最近更新日期2024/08/06
药物ATC编码
    • G04BD11 fesoterodine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase